SCHEMBL23999409

SCHEMBL23999409

Cc1cc(Nc2ccc3[nH]c(-c4ccc(Nc5cc(C)nc6ccc(C#N)cc56)cn4)nc3n2)ccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 4/20 0.40
▸ ROCK2 O75116 1/20 0.36
▸ METAP2 P50579 1/20 0.35
▸ METAP1 P53582 1/20 0.35
▸ MAPKAPK2 P49137 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ GAK O14976 1/20 0.34
▸ RIPK2 O43353 1/20 0.34
▸ COQ8A Q8NI60 1/20 0.34
▸ NLK Q9UBE8 1/20 0.34
▸ CSNK1A1 P48729 3/20 0.34
▸ CSNK1D P48730 3/20 0.34
▸ GSK3B P49841 3/20 0.34
▸ CSNK1G2 P78368 3/20 0.34
▸ TERT O14746 2/20 0.34
▸ DOT1L Q8TEK3 1/20 0.34
▸ EHMT2 Q96KQ7 1/20 0.33
▸ POLB P06746 1/20 0.32
▸ RAD52 P43351 1/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23999399 0.93 MAPKAPK2 (0.42) LRRK2ROCK2METAP2METAP1MAPKAPK2
SCHEMBL23999403 0.90 LRRK2 (0.43) LRRK2ROCK2MAPKAPK2L3MBTL1GAK
SCHEMBL23999407 0.87 LRRK2 (0.38) LRRK2ROCK2MAPKAPK2GAKRIPK2
SCHEMBL23999480 0.84 DNMT1 (0.38) POLBRAD52SMN1; SMN2
SCHEMBL23999751 0.84 LRRK2 (0.38) LRRK2METAP2METAP1MAPKAPK2L3MBTL1
SCHEMBL25484070 0.83 SLC2A1 (0.33) L3MBTL1TERTDOT1LEHMT2POLB
SCHEMBL23999401 0.82 MAPKAPK2 (0.51) LRRK2MAPKAPK2GAKRIPK2COQ8A
SCHEMBL23999377 0.82 MAPT (0.46) POLBRAD52SMN1; SMN2SLC2A1
SCHEMBL30180366 0.82 MAPT (0.46) POLBRAD52SMN1; SMN2SLC2A1
SCHEMBL23999400 0.79 MAPKAPK2 (0.43) LRRK2ROCK2MAPKAPK2GAKRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 — — US disclosed
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 — — US disclosed
WO-2023081854-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2023-05-11 — — WO disclosed
WO-2021226519-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR LRRK2 500/4885ROCK2 1345/4885METAP2 3759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback